1. Home
  2. Analysis
  3. Tamsulosin-hydrochloride
  4. Tarceva

Tamsulosin hydrochloride and Tarceva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tamsulosin hydrochloride (tamsulosin hydrochloride) and Tarceva (erlotinib hydrochloride). Common drug interactions include rash among males.

The phase IV clinical study analyzes what interactions people have when they take Tamsulosin hydrochloride and Tarceva. It is created by eHealthMe based on reports of 8 people who take the same drugs from the FDA, and is updated regularly.

What is Tamsulosin hydrochloride?

Tamsulosin hydrochloride has active ingredients of tamsulosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 18,328 Tamsulosin hydrochloride users. Check the latest studies of Tamsulosin hydrochloride.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.

On Feb, 04, 2026

8 people who take Tamsulosin hydrochloride and Tarceva together, and have interactions are studied.

Tamsulosin hydrochloride and Tarceva drug interactions.

What are the common drug interactions of Tamsulosin Hydrochloride and Tarceva, by gender? *:

female:

n/a

male:

  1. Rash
  2. Death
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Interstitial lung disease
  5. Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
  6. Lung disorder (lung disease)
  7. Metastases to lung (cancer spreads to lung)
  8. Nausea (feeling of having an urge to vomit)
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Pleural effusion (water on the lungs)

What are the common drug interactions of Tamsulosin Hydrochloride and Tarceva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Rash
  2. Diarrhoea
  3. Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
  4. Lung disorder (lung disease)
  5. Metastases to lung (cancer spreads to lung)
  6. Nausea (feeling of having an urge to vomit)
  7. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  8. Pleural effusion (water on the lungs)
  9. Right atrial dilatation (enlargement of the right atrium chamber of heart)
  10. Skin disorder (skin disease)

* Approximation only. Some reports may have incomplete information.

Do you take Tamsulosin hydrochloride and Tarceva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tamsulosin hydrochloride and Tarceva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tamsulosin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tarceva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tamsulosin hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tarceva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tamsulosin hydrochloride and erlotinib hydrochloride (the active ingredients of Tamsulosin hydrochloride and Tarceva, respectively), and Tamsulosin hydrochloride and Tarceva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.